{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T19:12:38Z","timestamp":1718392358747},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.leukres.2011.07.018","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T01:23:42Z","timestamp":1313544222000},"page":"1564-1570","source":"Crossref","is-referenced-by-count":9,"title":["Meta-analysis of human leukocyte antigen genetic polymorphisms and susceptibility to chronic myelogenous leukemia in Chinese population"],"prefix":"10.1016","volume":"35","author":[{"given":"Min-Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.07.018_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0167-5699(91)90017-N","article-title":"Map of the human MHC","volume":"12","author":"Trowsdale","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.leukres.2011.07.018_bib0010","series-title":"Practice of internal medicine","author":"Chen","year":"2001"},{"key":"10.1016\/j.leukres.2011.07.018_bib0015","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V85.10.2680.bloodjournal85102680","article-title":"Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules","volume":"85","author":"Bocchia","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.018_bib0020","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587","article-title":"Specific human cellular immunity to bcr-abl oncogene-derived peptides","volume":"87","author":"Bocchia","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.018_bib0025","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1038\/sj.leu.2402742","article-title":"Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes","volume":"16","author":"Makita","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.07.018_bib0030","first-page":"3863","article-title":"HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The chronic leukemia working party of the EBMT","volume":"93","author":"Posthuma","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.018_bib0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10428190802668873","article-title":"HLA risk markers for chronic myelogenous leukemia in Eastern Canada","volume":"50","author":"Naugler","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.07.018_bib0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10428190500287117","article-title":"Human leukocyte antigens in Indian patients with chronic myeloid leukemia","volume":"47","author":"Chhaya","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.07.018_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.leukres.2011.07.018_bib0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.leukres.2011.07.018_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.leukres.2011.07.018_bib0060","first-page":"619","article-title":"Correlation between the polymorphism of HLA-A,-B, and -DRB1 alleles and susceptibility to leukemia","volume":"21","author":"Zhou","year":"2005","journal-title":"Chin J Cell Mol Immunol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0065","first-page":"34","article-title":"Association between HLA-DRB1 alleles polymorphism and susceptibility to leukemia","volume":"33","author":"Zhou","year":"2007","journal-title":"J Lanzhou Univ (Medical Sciences)"},{"key":"10.1016\/j.leukres.2011.07.018_bib0070","first-page":"406","article-title":"Correlation between gene HLA-class I polymorphism and susceptibility to leukemia","volume":"28","author":"Zhou","year":"2007","journal-title":"J Xi\u2019an Jiaotong Univ (Medical Sciences)"},{"key":"10.1016\/j.leukres.2011.07.018_bib0075","first-page":"90","article-title":"Association HLA antigens and children patients with acute leukemia","volume":"21","author":"Duan","year":"2000","journal-title":"Chin J Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0080","first-page":"29","article-title":"Association of gene HLA-DQB1 and DRB1 with leukemia in Han nationality in Henan","volume":"22","author":"Zhao","year":"2008","journal-title":"J Practical Diagn Ther"},{"key":"10.1016\/j.leukres.2011.07.018_bib0085","first-page":"244","article-title":"Association of gene HLA-A, B, DRB1 polymorphism with leukemia in Han nationality in Shanxi","volume":"9","author":"Feng","year":"2009","journal-title":"Chin Remedies Clin"},{"key":"10.1016\/j.leukres.2011.07.018_bib0090","first-page":"693","article-title":"HLA class-I antigens in Gansu Chinese Han nationality with leukemia","volume":"20","author":"Zhao","year":"2004","journal-title":"Chin J Immunol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0095","first-page":"97","article-title":"Polymorphism of HLA-A, HLA-B and DRB1 alleles and haplotypes in Chinese northern Han patients with acute leukemia and chronic myeloid leukemia","volume":"31","author":"Gao","year":"2008","journal-title":"INT J Blood Transfus & Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0100","first-page":"149","article-title":"Polymorphism of HLA alleles in chronic myelogenous leukemia","volume":"16","author":"Lin","year":"1995","journal-title":"Chin J Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0105","first-page":"788","article-title":"HLA-DRBl allele polymorphosim associated with susceptibility to leukemia in Han nationality of Gansu","volume":"13","author":"Cao","year":"2005","journal-title":"J Exp Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0110","first-page":"401","article-title":"Analysis of HLA-DRB1 alleles in Fujian Chinese patients with chronic myelogenous leukemia","volume":"38","author":"Jin","year":"2004","journal-title":"J Fujian Med Univ"},{"key":"10.1016\/j.leukres.2011.07.018_bib0115","first-page":"1260","article-title":"Analysis of correlation between gene HLA gene polymorphosim and susceptibility to chronic myelogenous leukemia and acute lymphoblastic leukemia","volume":"26","author":"He","year":"2006","journal-title":"Basic Clin Med"},{"key":"10.1016\/j.leukres.2011.07.018_bib0120","first-page":"243","article-title":"Analysis of association between gene HLA and chronic myelogenous leukemia","volume":"14","author":"Li","year":"2001","journal-title":"Chin J Blood Transfus"},{"key":"10.1016\/j.leukres.2011.07.018_bib0125","first-page":"278","article-title":"Association between HLA-DRB1 allele polymorphism and susceptibility to acute lymphoblastic leukemia and chronic myelogenous leukemia in Chinese Han","volume":"21","author":"Cao","year":"2001","journal-title":"Chin J Microbiol Immunol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0130","first-page":"126","article-title":"Analysis of HLA-DRB1 alleles in Fujian Chinese patients with acute lymphoblastic leukemia and chronic myelogenous leukemia","volume":"27","author":"Jin","year":"2005","journal-title":"Fujian Med J"},{"key":"10.1016\/j.leukres.2011.07.018_bib0135","first-page":"316","article-title":"A study on the correlation of HLA gene and leukemia patients observed in southern Chinese Han population","volume":"23","author":"Zhou","year":"2005","journal-title":"Jiangxi J. Med Lab Sci"},{"key":"10.1016\/j.leukres.2011.07.018_bib0140","first-page":"563","article-title":"Association of gene HLA class I with Leukemia","volume":"13","author":"Li","year":"2005","journal-title":"J Exp Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0145","first-page":"986","article-title":"Analysis of HLA-DRB1 allele polymorphism in Guangdong Han patients with chronic myeloid leukemia","volume":"23","author":"Ding","year":"2007","journal-title":"J Practical Med"},{"key":"10.1016\/j.leukres.2011.07.018_bib0150","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1080\/10428190701632830","article-title":"Human leukocyte antigens in 295 Chinese patients with chronic myeloid leukemia","volume":"48","author":"Miao","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.07.018_bib0155","first-page":"310","article-title":"The study of the correlation between the polymorphism of HLA alleles and chronicmyelogenous leukemia","volume":"9","author":"Nie","year":"2007","journal-title":"J Clin Transfus Lab Med"},{"key":"10.1016\/j.leukres.2011.07.018_bib0160","first-page":"1114","article-title":"HLA associations with severe hematologic diseases","volume":"30","author":"Wang","year":"2007","journal-title":"Chin J Lab Med"},{"key":"10.1016\/j.leukres.2011.07.018_bib0165","first-page":"1016","article-title":"Association of HLA-A, B and DRB1 alleles with leukemia in Han population in Hunan province","volume":"28","author":"Luo","year":"2008","journal-title":"J South Med Univ"},{"key":"10.1016\/j.leukres.2011.07.018_bib0170","first-page":"915","article-title":"Expression and analysis of HLA-A, B and DRB1 genes in patients with chronic myelogenous leukemia in Guangdong area","volume":"16","author":"Wei","year":"2008","journal-title":"J Exp Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0175","series-title":"Proceedings of Southwest Blood Transfusion Academic Annual Meeting","first-page":"346","article-title":"Study of the correlation between the polymorphism of HLA alleles and the patients with chronic myelogenous leukemia in Chongqing area","author":"Wang","year":"2009"},{"key":"10.1016\/j.leukres.2011.07.018_bib0180","first-page":"309","article-title":"Association between HLA-DRB1 allele polymorphism and susceptibility to chronic myelogenous leukemia in Chinese Han","volume":"26","author":"Huo","year":"2010","journal-title":"Chin J Immunol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0185","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood.V98.5.1498","article-title":"HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4 (+) T lymphocytes","volume":"98","author":"Yasukawa","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.018_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00262-002-0362-7","article-title":"The abl\/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl\/bcr can be recognized by both CD4+ and CD8+ T lymphocytes","volume":"52","author":"Wagner","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2011.07.018_bib0195","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.leu.2401774","article-title":"HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)","volume":"14","author":"Posthuma","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.07.018_bib0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1096-8652(200002)63:2<99::AID-AJH8>3.0.CO;2-#","article-title":"Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogenous leukemia","volume":"63","author":"Yasukawa","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2011.07.018_bib0205","first-page":"137","article-title":"HLA class II allele and haplotype frequencies in Iranian patients with leukemia","volume":"6","author":"Khosravi","year":"2007","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"10.1016\/j.leukres.2011.07.018_bib0210","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/10428191003802340","article-title":"Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis","volume":"51","author":"Naugler","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.07.018_bib0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2370.2002.00359.x","article-title":"Nomenclature for factors of the HLA system","volume":"29","author":"Marsh","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.leukres.2011.07.018_bib0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.leu.2401946","article-title":"Is HLA-DR4 or the HLA-DRB1*0402 allele associated with decreased risk for CML?","volume":"15","author":"Pawelec","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.07.018_bib0225","first-page":"472","article-title":"Principal component analysis of gene frequencies of Chinese populations","volume":"43","author":"Xiao","year":"2000","journal-title":"Sci. China C Life Sci"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T09:53:10Z","timestamp":1592819590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0145212611003651"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.07.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}